Anesthesia in retinopathy of prematurity

Ruba Alselaimy1, Layan Al Tawil1, Marwan A Abouammoh1

  • 1Department of Ophthalmology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.

Insights

Topical proparacaine eases pain during retinopathy of prematurity (ROP) screening. Topical tetracaine is effective for ROP treatment injections, while general anesthesia is common for ROP photocoagulation.

Area of Science:

  • Ophthalmology
  • Neonatology
  • Anesthesiology

Background:

  • Retinopathy of prematurity (ROP) is a leading cause of childhood blindness.
  • Premature infants undergoing ROP screening or treatment are at higher risk for complications and adverse anesthetic effects.
  • Optimizing analgesia and anesthesia is crucial for ROP management.

Purpose of the Study:

  • To review and compare analgesic and anesthetic methods for retinopathy of prematurity (ROP) screening and treatment.
  • To provide ophthalmologists with current anesthetic practices for ROP patients.

Main Methods:

  • Systematic electronic literature search of MEDLINE, PubMed, and Embase.
  • Inclusion of randomized clinical trials, large case series, and surveys.
  • Keywords: ROP, ROP screening, ROP treatment, analgesia, anesthesia.

Main Results:

  • Topical proparacaine is the most common anesthesia for ROP screening, effectively reducing pain.
  • Comfort measures aid infant recovery but do not eliminate pain during screening.
  • Topical tetracaine shows efficacy for pain relief during intravitreal injections for ROP treatment.
  • General anesthesia is the standard for peripheral retinal photocoagulation in ROP treatment.

Conclusions:

  • Current anesthetic practices for ROP screening and treatment vary.
  • Further research is needed to fully understand optimal anesthesia options for ROP patients.
  • This review highlights current anesthetic and analgesic strategies for ROP management.